New clinical trial-->Phase II trial for Erbitux in triple negative breast cancer. <A HREF="http://clinicaltrials.gov/ct/show/NCT00420329?order=1" target="_blank">http://clinicaltrials.gov/ct/show/NCT00420329?order=1</A> biophud